In addition, multiple myeloma-derived epidermal growth factor receptor (EGFR) ligand amphiregulin-enriched exosomes were shown to promote EGFR pathway activation, inhibit osteoblast differentiation, and induce osteoclastogenesis [22]. Here, EGFR is linked to plasma cell myeloma.